Raymond James initiates coverage on Leap Therapeutics (NASDAQ: LPTX) with a Outperform rating and a price target of $13.00.Analyst Dr ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE